Genetic Manipulation of MRSA Using CRISPR/Cas9 Technology

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• The clustered regularly interspersed short palindromic repeat (CRISPR)/Cas9 system offers efficient and versatile genome engineering.
• CRISPR/Cas9 enables rapid genome editing in Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), by creating targeted DNA breaks.
• Base editors, engineered from cytidine deaminase APOBEC1 and Cas9 nickase, provide tools for gene inactivation and point mutations in S. aureus.

Purpose of the Study:

• To provide a detailed protocol for CRISPR/Cas9-based genome editing in Staphylococcus aureus.
• To outline methods for both genome modification and base editing in S. aureus.
• To facilitate rapid and efficient genetic manipulation of S. aureus strains.

Main Methods:

• Design of primers for targeted mutagenesis.
• Construction and transformation of CRISPR/Cas9 editing plasmids.
• Verification of sequence-specific, CRISPR/Cas9-mediated mutagenesis in S. aureus.

Main Results:

• Establishment of a comprehensive protocol for CRISPR/Cas9 genome editing in S. aureus.
• Demonstration of efficient genome modification and base editing capabilities.
• Successful verification of targeted mutagenesis in S. aureus.

Conclusions:

• The described protocol enables efficient and versatile genome editing in Staphylococcus aureus using CRISPR/Cas9 technology.
• The developed base editing system offers a powerful tool for gene inactivation and point mutation introduction.
• This methodology supports advancements in understanding and combating S. aureus infections, including MRSA.